Sleep and Headache

ABSTRACT

There is a strong interaction between sleep and headache. Sleep and headache disorders overlap epidemiologically, and share elements of anatomy and physiology. Perhaps as a result, their treatment is often mutually interdependent. Despite this, headache and sleep disorders tend to be treated separately, by different subspecialties of neurology. The headache disorders and their relationship to sleep, the commonalities of headache and sleep pathophysiology, and headache disorders that are particularly susceptible to sleep modulation (and vice versa) are reviewed. Practical management advice for sleep-modulated headaches is provided.

KEYWORDS

Headache - sleep - migraine - arousal

REFERENCES

• 1 Rains J C, Poceta J S. Headache and sleep disorders: review and clinical implications for headache management.  Headache. 2006;  46(9) 1344-1363
• 2 Dodick D W, Eross E J, Parish J M, Silber M. Clinical, anatomical, and physiologic relationship between sleep and headache.  Headache. 2003;  43(3) 282-292
• 3 Rains J C, Poceta J S, Penzien D B. Sleep and headaches.  Curr Neurol Neurosci Rep. 2008;  8(2) 167-175
• 4 Rains J C, Poceta J S. Sleep-related headache syndromes.  Semin Neurol. 2005;  25(1) 69-80
• 5 Jennum P, Jensen R. Sleep and headache.  Sleep Med Rev. 2002;  6(6) 471-479
• 6 Saper C B, Scammell T E, Lu J. Hypothalamic regulation of sleep and circadian rhythms.  Nature. 2005;  437(7063) 1257-1263
• 7 Fuller P M, Gooley J J, Saper C B. Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback.  J Biol Rhythms. 2006;  21(6) 482-493
• 8 Porkka-Heiskanen T, Strecker R E, Thakkar M, Bjorkum A A, Greene R W, McCarley R W. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness.  Science. 1997;  276(5316) 1265-1268
• 9 Aston-Jones G, Chen S, Zhu Y, Oshinsky M L. A neural circuit for circadian regulation of arousal.  Nat Neurosci. 2001;  4(7) 732-738
• 10 Lu J, Sherman D, Devor M, Saper C B. A putative flip-flop switch for control of REM sleep.  Nature. 2006;  441(7093) 589-594
• 11 Craig A DB. Pain mechanisms: labeled lines versus convergence in central processing.  Annu Rev Neurosci. 2003;  26 1-30
• 12 Saper C B. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation.  Annu Rev Neurosci. 2002;  25 433-469
• 13 Benarroch E E. Pain-autonomic interactions.  Neurol Sci. 2006;  27(Suppl 2) S130-S133
• 14 Raskin N H, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain.  Headache. 1987;  27(8) 416-420
• 15 Ostrowsky K, Magnin M, Ryvlin P, Isnard J, Guenot M, Mauguière F. Representation of pain and somatic sensation in the human insula: a study of responses to direct electrical cortical stimulation.  Cereb Cortex. 2002;  12(4) 376-385
• 16 Keller J T, Saunders M C, Beduk A, Jollis J G. Innervation of the posterior fossa dura of the cat.  Brain Res Bull. 1985;  14(1) 97-102
• 17 Ray B, Wolff H. Experimental studies on headache: pain-sensitive structures of the head and their significance in headache.  Arch Surg. 1940;  41(4) 813-856
• 18 Ter Horst G J, Meijler W J, Korf J, Kemper R H. Trigeminal nociception-induced cerebral Fos expression in the conscious rat.  Cephalalgia. 2001;  21(10) 963-975
• 19 Malick A, Burstein R. Cells of origin of the trigeminohypothalamic tract in the rat.  J Comp Neurol. 1998;  400(1) 125-144
• 20 Edvinsson L, Uddman R. Neurobiology in primary headaches.  Brain Res Brain Res Rev. 2005;  48(3) 438-456
• 21 Porreca F, Ossipov M H, Gebhart G F. Chronic pain and medullary descending facilitation.  Trends Neurosci. 2002;  25(6) 319-325
• 22 Porreca F. Presidential symposium: Descending facilitation. Paper presented at: 50th Annual Scientific Meeting of the American Headache Society June 26–29, 2008 Boston, MA;
• 23 Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine.  J Comp Neurol. 2005;  493(1) 9-14
• 24 Holland P, Akerman S, Lasalandra M, Goadsby P. Orexin A antinociceptive effects in the ventrolateral periaqueductal gray are blocked by 5HT 1B/D receptor antagonism (abstract). Abstract presented at: 133rd Annual Meeting of the American Neurological Association September 21–24, 2008 Salt Lake City, UT;
• 25 Holland P R, Akerman S, Goadsby P J. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.  Eur J Neurosci. 2006;  24(10) 2825-2833
• 26 Holland P R, Akerman S, Goadsby P J. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.  J Pharmacol Exp Ther. 2005;  315(3) 1380-1385
• 27 Weiller C, May A, Limmroth V et al.. Brain stem activation in spontaneous human migraine attacks.  Nat Med. 1995;  1(7) 658-660
• 28 Afridi S, Goadsby P J. New onset migraine with a brain stem cavernous angioma.  J Neurol Neurosurg Psychiatry. 2003;  74(5) 680-682
• 29 Rocca M A, Ceccarelli A, Falini A et al.. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study.  Stroke. 2006;  37(7) 1765-1770
• 30 Veloso F, Kumar K, Toth C. Headache secondary to deep brain implantation.  Headache. 1998;  38(7) 507-515
• 31 May A, Bahra A, Büchel C, Frackowiak R S, Goadsby P J. Hypothalamic activation in cluster headache attacks.  Lancet. 1998;  352(9124) 275-278
• 32 Matharu M S, Cohen A S, Frackowiak R SJ, Goadsby P J. Posterior hypothalamic activation in paroxysmal hemicrania.  Ann Neurol. 2006;  59(3) 535-545
• 33 Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle T R. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression.  Pain. 2005;  113(3) 422-426
• 34 May A, Bahra A, Büchel C, Turner R, Goadsby P J. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.  Ann Neurol. 1999;  46(5) 791-794
• 35 Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks.  Headache. 2007;  47(10) 1418-1426
• 36 Hsieh J C, Ståhle-Bäckdahl M, Hägermark O, Stone-Elander S, Rosenquist G, Ingvar M. Traumatic nociceptive pain activates the hypothalamus and the periaqueductal gray: a positron emission tomography study.  Pain. 1996;  64(2) 303-314
• 37 Jacquet Y F, Lajtha A. Morphine action at central nervous system sites in rat: analgesia or hyperalgesia depending on site and dose.  Science. 1973;  182(4111) 490-492
• 38 Leone M, Proietti Cecchini A, Franzini A et al.. Lessons from 8 years' experience of hypothalamic stimulation in cluster headache.  Cephalalgia. 2008;  28(7) 787-797 discussion 798
• 39 Xie X, Wisor J P, Hara J et al.. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia.  J Clin Invest. 2008;  118(7) 2471-2481
• 40 Thannickal T C, Moore R Y, Nienhuis R et al.. Reduced number of hypocretin neurons in human narcolepsy.  Neuron. 2000;  27(3) 469-474
• 41 Jacobson K A, Gao Z G. Adenosine receptors as therapeutic targets.  Nat Rev Drug Discov. 2006;  5(3) 247-264
• 42 Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D. Adenosine and sleep.  Sleep Med Rev. 2002;  6(4) 321-332
• 43 Landolt H P. Sleep homeostasis: a role for adenosine in humans?.  Biochem Pharmacol. 2008;  75(11) 2070-2079
• 44 Satoh S, Matsumura H, Suzuki F, Hayaishi O. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats.  Proc Natl Acad Sci U S A. 1996;  93(12) 5980-5984
• 45 Rétey J V, Adam M, Honegger E et al.. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans.  Proc Natl Acad Sci U S A. 2005;  102(43) 15676-15681
• 46 De Lander G E, Keil II G J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.  J Pharmacol Exp Ther. 1994;  268(2) 943-951
• 47 Wu W P, Hao J X, Halldner L et al.. Increased nociceptive response in mice lacking the adenosine A1 receptor.  Pain. 2005;  113(3) 395-404
• 48 Goadsby P J, Hoskin K L, Storer R J, Edvinsson L, Connor H E. Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission.  Brain. 2002;  125(Pt 6) 1392-1401
• 49 Giffin N J, Kowacs F, Libri V, Williams P, Goadsby P J, Kaube H. Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects.  Cephalalgia. 2003;  23(4) 287-292
• 50 Gan T J, Habib A S. Adenosine as a non-opioid analgesic in the perioperative setting.  Anesth Analg. 2007;  105(2) 487-494
• 51 Ferré S, Diamond I, Goldberg S R et al.. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.  Prog Neurobiol. 2007;  83(5) 332-347
• 52 Shapiro R E. Caffeine and headaches.  Curr Pain Headache Rep. 2008;  12(4) 311-315
• 53 Kruuse C, Lassen L H, Iversen H K, Oestergaard S, Olesen J. Dipyridamole may induce migraine in patients with migraine without aura.  Cephalalgia. 2006;  26(8) 925-933
• 54 Brown S G, Waterer G W. Migraine precipitated by adenosine.  Med J Aust. 1995;  162(7) 389-391, 391
• 55 Esquisatto L C, Costa S K, Camargo E A et al.. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells.  Br J Pharmacol. 2001;  134(1) 108-115
• 56 Guieu R, Sampiéri F, Bechis G, Rochat H. Use of HPLC to measure circulating adenosine levels in migrainous patients.  Clin Chim Acta. 1994;  227(1-2) 185-194
• 57 Guieu R, Devaux C, Henry H et al.. Adenosine and migraine.  Can J Neurol Sci. 1998;  25(1) 55-58
• 58 Hohoff C, Marziniak M, Lesch K P, Deckert J, Sommer C, Mössner R. An adenosine A2A receptor gene haplotype is associated with migraine with aura.  Cephalalgia. 2007;  27(2) 177-181
• 59 Arendt J, Skene D J. Melatonin as a chronobiotic.  Sleep Med Rev. 2005;  9(1) 25-39
• 60 Chazot G, Claustrat B, Brun J, Jordan D, Sassolas G, Schott B. A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache.  Cephalalgia. 1984;  4(4) 213-220
• 61 Waldenlind E, Gustafsson S A, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission.  J Neurol Neurosurg Psychiatry. 1987;  50(2) 207-213
• 62 Leone M, Frediani F, D'Amico D et al.. Dexamethasone suppression test, melatonin and TRH-test in cluster headache.  Ital J Neurol Sci. 1992;  13(3) 227-232
• 63 Leone M, Lucini V, D'Amico D et al.. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache.  Cephalalgia. 1995;  15(3) 224-229
• 64 Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud J L, Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report.  Headache. 1989;  29(4) 242-245
• 65 Murialdo G, Fonzi S, Costelli P et al.. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine.  Cephalalgia. 1994;  14(3) 205-209
• 66 Claustrat B, Brun J, Chiquet C, Chazot G, Borson-Chazot F. Melatonin secretion is supersensitive to light in migraine.  Cephalalgia. 2004;  24(2) 128-133
• 67 Leone M, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups.  Cephalalgia. 1996;  16(7) 494-496
• 68 Vogler B, Rapoport A M, Tepper S J, Sheftell F, Bigal M E. Role of melatonin in the pathophysiology of migraine: implications for treatment.  CNS Drugs. 2006;  20(5) 343-350
• 69 Shapiro R E, Waheed W, Nagle K. A novel familial syndrome of migraine with aura, flushing spells, myalgias, asthma, and the advanced sleep phase syndrome.  Cephalalgia. 1999;  19 424 (Abstract)
• 70 Jones C R, Campbell S S, Zone S E et al.. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans.  Nat Med. 1999;  5(9) 1062-1065
• 71 Xu Y, Padiath Q S, Shapiro R E et al.. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.  Nature. 2005;  434(7033) 640-644
• 72 Brennan K, Beltran-Parrazal L, Lopez-Valdes H et al.. Reduced threshold for cortical spreading depression in mice transgenic for human CK1δ T44A.  Headache. 2006;  46(5) 840 , (Abstract)
• 73 Bolay H, Reuter U, Dunn A K, Huang Z, Boas D A, Moskowitz M A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.  Nat Med. 2002;  8(2) 136-142
• 74 Bates E. Defining the role of CK1 delta in migraine with aura. Paper presented at: 50th Annual Scientific Meeting of the American Headache Society June 26–29, 2008 Boston, MA;
• 75 Albus H, Deboer T, Ferrari M et al.. FHM1 R192Q Cacna1a mutant mice show enhanced adjustment to advanced shifts of the light-dark cycle: a molecular basis to chronobiology in migraine?.  Cephalalgia. 2007;  27(6) 624 (Abstract)
• 76 Martin V T, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis—part 2.  Headache. 2006;  46(3) 365-386
• 77 Cugini P, Romit A, Di Palma L, Giacovazzo M. Common migraine as a weekly and seasonal headache.  Chronobiol Int. 1990;  7(5-6) 467-469
• 78 Alstadhaug K B, Salvesen R, Bekkelund S I. Seasonal variation in migraine.  Cephalalgia. 2005;  25(10) 811-816
• 79 Alstadhaug K B, Bekkelund S, Salvesen R. Circannual periodicity of migraine?.  Eur J Neurol. 2007;  14(9) 983-988
• 80 Dexter J D, Riley T L. Studies in nocturnal migraine.  Headache. 1975;  15(1) 51-62
• 81 Solomon G D. Circadian rhythms and migraine.  Cleve Clin J Med. 1992;  59(3) 326-329
• 82 Fox A W, Davis R L. Migraine chronobiology.  Headache. 1998;  38(6) 436-441
• 83 Alstadhaug K, Salvesen R, Bekkelund S. 24-hour distribution of migraine attacks.  Headache. 2008;  48(1) 95-100
• 84 Hsu L K, Crisp A H, Kalucy R S et al.. Early morning migraine. Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and sleep encephalographs.  Lancet. 1977;  1(8009) 447-451
• 85 Dexter J D, Weitzman E D. The relationship of nocturnal headaches to sleep stage patterns.  Neurology. 1970;  20(5) 513-518
• 86 Dexter J D. The relationship between stage III + IV + REM sleep and arousals with migraine.  Headache. 1979;  19(7) 364-369
• 87 Göder R, Fritzer G, Kapsokalyvas A et al.. Polysomnographic findings in nights preceding a migraine attack.  Cephalalgia. 2001;  21(1) 31-37
• 88 Drake Jr M E, Pakalnis A, Andrews J M, Bogner J E. Nocturnal sleep recording with cassette EEG in chronic headaches.  Headache. 1990;  30(9) 600-603
• 89 Vendrame M, Kaleyias J, Valencia I, Legido A, Kothare S V. Polysomnographic findings in children with headaches.  Pediatr Neurol. 2008;  39(1) 6-11
• 90 Della Marca G, Vollono C, Rubino M, Di Trapani G, Mariotti P, Tonali P A. Dysfunction of arousal systems in sleep-related migraine without aura.  Cephalalgia. 2006;  26(7) 857-864
• 91 Bruni O, Russo P M, Violani C, Guidetti V. Sleep and migraine: an actigraphic study.  Cephalalgia. 2004;  24(2) 134-139
• 92 Russell D. Cluster headache: severity and temporal profiles of attacks and patient activity prior to and during attacks.  Cephalalgia. 1981;  1(4) 209-216
• 93 Pfaffenrath V, Pöllmann W, Rüther E, Lund R, Hajak G. Onset of nocturnal attacks of chronic cluster headache in relation to sleep stages.  Acta Neurol Scand. 1986;  73(4) 403-407
• 94 Sprenger T, Boecker H, Tolle T R, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack.  Neurology. 2004;  62(3) 516-517
• 95 May A, Ashburner J, Büchel C et al.. Correlation between structural and functional changes in brain in an idiopathic headache syndrome.  Nat Med. 1999;  5(7) 836-838
• 96 Lodi R, Pierangeli G, Tonon C et al.. Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy.  Neurology. 2006;  66(8) 1264-1266
• 97 Manzoni G C, Terzano M G, Moretti G, Cocchi M. Clinical observations on 76 cluster headache cases.  Eur Neurol. 1981;  20(2) 88-94
• 98 Rainero I, Gallone S, Valfrè W et al.. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache.  Neurology. 2004;  63(7) 1286-1288
• 99 Rainero I, Rubino E, Valfrè W et al.. Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis.  J Headache Pain. 2007;  8(3) 152-156
• 100 May A, Bahra A, Büchel C, Turner R, Goadsby P J. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.  Ann Neurol. 1999;  46(5) 791-794
• 101 Matharu M S, Cohen A S, Frackowiak R SJ, Goadsby P J. Posterior hypothalamic activation in paroxysmal hemicrania.  Ann Neurol. 2006;  59(3) 535-545
• 102 Goadsby P J, Cittadini E, Burns B, Cohen A S. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments.  Curr Opin Neurol. 2008;  21(3) 323-330
• 103 Evers S, Goadsby P J. Hypnic headache: clinical features, pathophysiology, and treatment.  Neurology. 2003;  60(6) 905-909
• 104 Dodick D W. Polysomnography in hypnic headache syndrome.  Headache. 2000;  40(9) 748-752
• 105 Evers S, Rahmann A, Schwaag S, Lüdemann P, Husstedt I W. Hypnic headache - the first German cases including polysomnography.  Cephalalgia. 2003;  23(1) 20-23
• 106 Liang J F, Fuh J L, Yu H Y, Hsu C Y, Wang S J. Clinical features, polysomnography and outcome in patients with hypnic headache.  Cephalalgia. 2008;  28(3) 209-215
• 107 Nishino S, Ripley B, Overeem S, Lammers G J, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy.  Lancet. 2000;  355(9197) 39-40
• 108 Peyron C, Faraco J, Rogers W et al.. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.  Nat Med. 2000;  6(9) 991-997
• 109 Dahmen N, Querings K, Grün B, Bierbrauer J. Increased frequency of migraine in narcoleptic patients.  Neurology. 1999;  52(6) 1291-1293
• 110 Dahmen N, Kasten M, Wieczorek S, Gencik M, Epplen J T, Ullrich B. Increased frequency of migraine in narcoleptic patients: a confirmatory study.  Cephalalgia. 2003;  23(1) 14-19
• 111 The DMKG Study Group . Migraine and idiopathic narcolepsy—a case-control study.  Cephalalgia. 2003;  23(8) 786-789
• 112 Reis D J, Golanov E V, Galea E, Feinstein D L. Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia.  Ann N Y Acad Sci. 1997;  835 168-186
• 113 Steen K H, Reeh P W. Sustained graded pain and hyperalgesia from harmless experimental tissue acidosis in human skin.  Neurosci Lett. 1993;  154(1-2) 113-116
• 114 Lindauer U, Vogt J, Schuh-Hofer S, Dreier J P, Dirnagl U. Cerebrovascular vasodilation to extraluminal acidosis occurs via combined activation of ATP-sensitive and Ca2+-activated potassium channels.  J Cereb Blood Flow Metab. 2003;  23(10) 1227-1238
• 115 Bruce B B, Kedar S, Van Stavern G P et al.. Idiopathic intracranial hypertension in men.  Neurology. 2009;  72(4) 304-309
• 116 Scher A I, Lipton R B, Stewart W F. Habitual snoring as a risk factor for chronic daily headache.  Neurology. 2003;  60(8) 1366-1368
• 117 Mitsikostas D D, Vikelis M, Viskos A. Refractory chronic headache associated with obstructive sleep apnoea syndrome.  Cephalalgia. 2008;  28(2) 139-143
• 118 Rhode A M, Hösing V G, Happe S, Biehl K, Young P, Evers S. Comorbidity of migraine and restless legs syndrome—a case-control study.  Cephalalgia. 2007;  27(11) 1255-1260
• 119 d'Onofrio F, Bussone G, Cologno D et al.. Restless legs syndrome and primary headaches: a clinical study.  Neurol Sci. 2008;  29(Suppl 1) S169-S172
• 120 Vgontzas A, Cui L, Merikangas K R. Are sleep difficulties associated with migraine attributable to anxiety and depression?.  Headache. 2008;  48(10) 1451-1459
• 121 Kelman L. The triggers or precipitants of the acute migraine attack.  Cephalalgia. 2007;  27(5) 394-402
• 122 Calhoun A H, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine.  Headache. 2007;  47(8) 1178-1183
• 123 Dorsey C M, Lee K A, Scharf M B. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.  Clin Ther. 2004;  26(10) 1578-1586
• 124 Krystal A D, Erman M, Zammit G K, Soubrane C, Roth T. ZOLONG Study Group . Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.  Sleep. 2008;  31(1) 79-90
• 125 Weitzel K W, Wickman J M, Augustin S G, Strom J G. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.  Clin Ther. 2000;  22(11) 1254-1267
• 126 Silberstein S D, Goadsby P J. Migraine: preventive treatment.  Cephalalgia. 2002;  22(7) 491-512
• 127 Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.  Br J Rheumatol. 1998;  37(12) 1279-1286
• 128 Versiani M, Ontiveros A, Mazzotti G et al.. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.  Int Clin Psychopharmacol. 1999;  14(6) 321-327
• 129 Casper R C, Katz M M, Bowden C L, Davis J M, Koslow S H, Hanin I. The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.  J Affect Disord. 1994;  31(3) 151-164
• 130 Brzezinski A, Vangel M G, Wurtman R J et al.. Effects of exogenous melatonin on sleep: a meta-analysis.  Sleep Med Rev. 2005;  9(1) 41-50